Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Roshan Karki, Marisa Mariani, Mirko Andreoli, Shiquan He, Giovanni Scambia, Shohreh Shahabi & Cristiano Ferlini. (2013) βIII-Tubulin: biomarker of taxane resistance or drug target?. Expert Opinion on Therapeutic Targets 17:4, pages 461-472.
Read now
Read now
Articles from other publishers (14)
Chen Yang, Tian Yu & Qin Lin. (2023) A Novel Signature Based on Anoikis Associated with BCR-Free Survival for Prostate Cancer. Biochemical Genetics 61:6, pages 2496-2513.
Crossref
Crossref
Haixiu Ma, Kaizhen Yang, Hongxia Li, Mengyu Luo, Reziwan Wufuer & Ling Kang. (2021) Photodynamic effect of chlorin e6 on cytoskeleton protein of human colon cancer SW480 cells. Photodiagnosis and Photodynamic Therapy 33, pages 102201.
Crossref
Crossref
Wellerson R Scarano, Amina Bedrat, Luiz G Alonso-Costa, Ariana M Aquino, Bruno E A Fantinatti, Luis A Justulin, Luis F Barbisan, Paula P Freire, Jodi A Flaws & Bernardo Lemos. (2019) Exposure to an Environmentally Relevant Phthalate Mixture During Prostate Development Induces MicroRNA Upregulation and Transcriptome Modulation in Rats. Toxicological Sciences 171:1, pages 84-97.
Crossref
Crossref
Yan-Ting Wang, Tian-Qi Shi, Hai-Liang Zhu & Chang-Hong Liu. (2019) Synthesis, biological evaluation and molecular docking of benzimidazole grafted benzsulfamide-containing pyrazole ring derivatives as novel tubulin polymerization inhibitors. Bioorganic & Medicinal Chemistry 27:3, pages 502-515.
Crossref
Crossref
Ruobing Cao, Weihua Jin, Yeqi Shan, Ju Wang, Ge Liu, Shan Kuang & Chaomin Sun. (2018) Marine Bacterial Polysaccharide EPS11 Inhibits Cancer Cell Growth via Blocking Cell Adhesion and Stimulating Anoikis. Marine Drugs 16:3, pages 85.
Crossref
Crossref
Fermín Person, Waldemar Wilczak, Claudia Hube-Magg, Christoph Burdelski, Christina Möller-Koop, Ronald Simon, Mercedes Noriega, Guido Sauter, Stefan Steurer, Susanne Burdak-Rothkamm & Frank Jacobsen. (2017) Prevalence of βIII-tubulin (TUBB3) expression in human normal tissues and cancers. Tumor Biology 39:10, pages 101042831771216.
Crossref
Crossref
Amelia L. Parker, Wee Siang Teo, Joshua A. McCarroll & Maria Kavallaris. (2017) An Emerging Role for Tubulin Isotypes in Modulating Cancer Biology and Chemotherapy Resistance. International Journal of Molecular Sciences 18:7, pages 1434.
Crossref
Crossref
Weiwei Wang, Hangxiao Zhang, Xumin Wang, Jordan Patterson, Philip Winter, Kathryn Graham, Sunita Ghosh, John C. Lee, Christos D. Katsetos, John R. Mackey, Jack A. Tuszynski, Gane Ka-Shu Wong & Richard F. Ludueña. (2016) Novel mutations involving βI-, βIIA-, or βIVB-tubulin isotypes with functional resemblance to βIII-tubulin in breast cancer. Protoplasma 254:3, pages 1163-1173.
Crossref
Crossref
Yan-Ting Wang, Ya-Juan Qin, Na Yang, Ya-Liang Zhang, Chang-Hong Liu & Hai-Liang Zhu. (2015) Synthesis, biological evaluation, and molecular docking studies of novel 1-benzene acyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as potential tubulin polymerization inhibitors. European Journal of Medicinal Chemistry 99, pages 125-137.
Crossref
Crossref
Christos D. Katsetos, Mauricio J. Reginato, Peter W. Baas, Luca D’Agostino, Agustin Legido, Jack A. Tuszyn´ski, Eduarda Dráberová & Pavel Dráber. (2015) Emerging Microtubule Targets in Glioma Therapy. Seminars in Pediatric Neurology 22:1, pages 49-72.
Crossref
Crossref
Joshua A. McCarroll, Pei Pei Gan, Rafael B. Erlich, Marjorie Liu, Tanya Dwarte, Sharon S. Sagnella, Mia C. Akerfeldt, Lu Yang, Amelia L. Parker, Melissa H. Chang, Michael S. Shum, Frances L. Byrne & Maria Kavallaris. (2015)
TUBB3
/βIII-Tubulin Acts through the PTEN/AKT Signaling Axis to Promote Tumorigenesis and Anoikis Resistance in Non–Small Cell Lung Cancer
. Cancer Research 75:2, pages 415-425.
Crossref
Crossref
Nathaniel Melling, Anastasia Martha Tsaklakidis, Ronald Simon, Philip Stahl, Carsten Bokemeyer, Luigi Terracciano, Guido Sauter, Jakob Robert Izbicki & Andreas Holger Marx. (2015) βIII-tubulin overexpression is linked to left-sided tumor localization and nuclear β-catenin expression in colorectal cancer. Cancer Treatment Communications 4, pages 96-102.
Crossref
Crossref
Maria C. Tsourlakis, Philipp Weigand, Katharina Grupp, Martina Kluth, Stefan Steurer, Thorsten Schlomm, Markus Graefen, Hartwig Huland, Georg Salomon, Thomas Steuber, Waldemar Wilczak, Hüseyin Sirma, Ronald Simon, Guido Sauter, Sarah Minner & Alexander Quaas. (2014) βIII-Tubulin Overexpression Is an Independent Predictor of Prostate Cancer Progression Tightly Linked to ERG Fusion Status and PTEN Deletion. The American Journal of Pathology 184:3, pages 609-617.
Crossref
Crossref
Peng Zhang, Xin Ma, Erlin Song, Weihao Chen, Haigang Pang, Dong Ni, Yu Gao, Yang Fan, Qiang Ding, Yu Zhang & Xu Zhang. (2013) Tubulin cofactor A functions as a novel positive regulator of ccRCC progression, invasion and metastasis. International Journal of Cancer, pages n/a-n/a.
Crossref
Crossref